Nutex Health (NUTX) Gross Margin (2010 - 2026)

Nutex Health has disclosed Gross Margin across 17 years of filings, most recently posting 42.37% for Q1 2026.

• Gross Margin for Q1 2026 came in at 42.37%, down 1350.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 47.47% (down 130.0% YoY), and the FY2025 annual result was 50.76%, up 987.0% from the prior year.
• Gross Margin came in at 42.37% for Q1 2026 at Nutex Health, up from 30.42% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 57.83% in Q3 2025 to a low of 93.21% in Q3 2022.
• The 5-year median for Gross Margin is 27.82% (2024), against an average of 22.64%.
• Across the five-year window, Gross Margin sank 15764 bps in 2022 and surged 10448 bps in 2023, its largest moves.
• Nutex Health's Gross Margin stood at 0.99% in 2022, then surged by 1821 bps to 18.97% in 2023, then surged by 190 bps to 54.98% in 2024, then tumbled by 45 bps to 30.42% in 2025, then soared by 39 bps to 42.37% in 2026.
• The last three Gross Margin figures came in at 42.37% (Q1 2026), 30.42% (Q4 2025), and 57.83% (Q3 2025), per Business Quant data.